Related Experiment Video
Updated: Jul 4, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Mobile versus in-center ECMO initiation in pediatric patients: a comparative outcome study
Jowita Rosada-Kurasińska1, Bartłomiej Kociński2, Mark T Ogino3
1Poznan University of Medical Sciences, Department of Paediatric Anaesthesiology and Intensive Therapy.
Insights
Extracorporeal life support (ECLS) initiated at local hospitals by mobile teams and transported to specialized centers shows comparable outcomes to in-center ECLS. This approach is safe and effective for pediatric patients with severe respiratory or cardiopulmonary failure.
Area of Science:
- Pediatric critical care medicine
- Cardiopulmonary support technologies
- Inter-hospital patient transfer protocols
Background:
- Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for severe respiratory or cardiopulmonary failure.
- Persistent hypoxemia or hypercapnia despite maximal conventional therapy necessitates advanced support.
- Indications for ECMO include conditions threatening life due to inadequate gas exchange.
Purpose of the Study:
- To compare the characteristics and outcomes of pediatric patients receiving ECMO initiated at a specialized center versus those initiated at local hospitals followed by mobile ECMO team transport.
- Evaluate the safety and efficacy of mobile ECMO services in pediatric critical care.
- Assess the impact of transport on patient outcomes.
Main Methods:
- Retrospective analysis of pediatric patients who received ECMO between 2018 and 2025.
- Comparison of two groups: ECMO initiated at the specialized center (control) and ECMO initiated at local hospitals by a mobile cardiorespiratory assistance unit (mobile group).
- Data collected included demographics, pre-ECMO parameters, and clinical outcomes such as survival, organ dysfunction, and support duration.
Main Results:
- Twenty-four pediatric patients were analyzed. The mobile group (15 patients) had 80% survival to discharge, primarily for pediatric acute respiratory distress syndrome (PARDS). The control group (9 patients) had 78% survival.
- No statistically significant differences were observed between groups in hepatic dysfunction, kidney failure, successful weaning, duration of extracorporeal support, pre-ECMO ICU stay, or ICU mortality.
- Both approaches demonstrated similar clinical outcomes, supporting the feasibility of mobile ECMO initiation.
Conclusions:
- Bedside initiation of Extracorporeal Life Support (ECLS) in local hospitals by mobile teams is safe and effective, with subsequent transport to referral centers yielding comparable outcomes.
- The study validates the effectiveness of establishing an interregional network of mobile cardiorespiratory assistance units for pediatric critical care.
- Mobile ECMO services facilitate timely access to advanced life support for critically ill children, regardless of initial hospital capabilities.
Background:
ECMO is indicated for respiratory or cardiopulmonary failure despite high oxygen levels, advanced ventilation, and patient optimization, when persistent hypoxemia/hypercapnia threatens life.
Aim:
Compare characteristics and outcomes of children receiving ECLS at a specialized center vs. local hospital initiation followed by mobile ECMO team transport.
Material And Methods:
A retrospective analysis was conducted of all pediatric patients who received ECMO support in our PICU between 2018 and 2025. Extracorporeal life support was initiated either at our center or at local hospitals by a mobile cardiorespiratory assistance unit. Data collected included demographic characteristics, pre-ECMO parameters, and clinical outcomes.
Results:
24 children who underwent ECLS were analyzed. In the mobile group, 15 patients supported with VV ECMO were transported from regional hospitals to our ECMO center; PARDS with failure of conventional therapy was the main indication, and 80% survived to hospital discharge. In the control group, 9 children received either VV or VA ECMO, depending on the underlying respiratory or combined respiratory/cardiac failure, with 78% survival to discharge. Hepatic dysfunction and kidney failure occurred in 47% and 33% of the mobile group, and in 67% and 44% of the control group, respectively, with no statistically significant differences between groups. There were also no significant differences in successful weaning, duration of extracorporeal support, ICU length of stay before ECMO, or ICU mortality rate.
Conclusions:
ECLS can be safely initiated bedside in local hospitals with transport to referral centers. Our findings confirmed the effectiveness of establishing an interregional network of mobile cardiorespiratory assistance units.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Mechanical Ventilation I: Indication and Settings
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Respiratory Failure-III